Global Diagnostic Reagents Market By Type (In Vivo Diagnostic, In Vitro Diagnostic – Clinical Biochemical, Immunodiagnostic reagents, Molecular Diagnostic); By Application/ Test Type (Cardiovascular Test – Human Fatty Acid Binding Protein Test, Cardiac Troponin Test, Homocysteine Test, Others, Infection Test, Renal Function Test – Hemoglobin A1c Test, Microalbumin Test, Cystine Test, Retinol Binding Protein Test, Others, Rheumatism Test – Rheumatoid Factor Test, Anti CCP, Antistreptolysin O Test, Gastric Function Test – Pepsinogen I Test, Pepsinogen II (PGII) Test, Liver Test – Prealbumin Blood Test, Transferrin Blood Test, Complement 4 Blood Test, Others, Hormone Test – Thyroid Stimulating Hormone protein test, Total Thyroxine Test, Human Chorionic Gonadotropin Test, Others, Autoimmunity Test – Immune Globulin A Test, Immune Globulin M Test, Immune Globulin E Test, Others, Others); By End Users (Hospitals and Clinics, Research centers and Laboratories, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
The global diagnostic reagents market was valued at US$ 45.8 Bn in 2021, projected to grow at an estimated CAGR of 8% over the forecast period. Finding a root cause of any disease by studying symptoms or through a certain procedure is known as diagnosis. This is definitely the first step towards treatment of any diseases and hence holds utmost importance. Diagnostic reagents are proving utterly helpful in the treatment of several ailments. Diagnostic reagents basically are those medical reagents produced through processes or principles regarding molecular biology, microbiology and immunology are utilized in vitro for the purpose of epidemiological investigation and diagnosis detection of any disease linked with human beings. Primarily the diagnostic reagents are segregated into in vivo diagnostic reagents and in vitro diagnostic reagents. The diagnostic reagents market is growing rampantly due to surge in the need for latest diagnosis techniques, especially in diseases that are infectious and chronic in nature.
The diagnostic reagents market witnessed massive boost due to the recent COVID-19 pandemic. The highly infectious virus killed several millions across the globe and diagnostic reagents proved more than helpful in determining their severity. This spiked demand for them, ultimately helping the market generate more revenue.
Type Outlook
On the basis of type, the diagnostic reagents market has been divided into in vivo diagnostic and in vitro diagnostic. The in vitro diagnostic segment has been further categorised into clinical biochemical, immunodiagnostic reagents and molecular diagnostic. While in vivo diagnostic is basically, the diagnostic done with or within humans, the in vitro diagnostic is done outside a living being.
Global Diagnostic Reagents Market Revenue & Forecast, (US$ Million), 2022 – 2030
Application Outlook
On the basis of application, the diagnostic reagents market has been categorised into cardiovascular test, infection test, renal function test, rheumatism test, gastric function test, liver test, hormone test, autoimmunity test and others. While the cardiovascular test segment is further segmented into human fatty acid binding protein test, cardiac troponin test, homocysteine test, and others, the renal function test segment is bifurcated into haemoglobin A1c test, microalbumin test, cysteine test, retinol binding protein test and others. The rheumatism test segment is further categorised into rheumatoid factor test, anti CCP test and antistreptolysin O test, while the gastric function test segment is divided into pepsinogen I test, and pepsinogen II (PGII) test. On the other hand, the liver test segment is further bifurcated into prealbumin blood test, transferring blood test, complement 4 blood test and others, the hormone test segment is divided into thyroid stimulating hormone protein test, total thyroxine test, human chorionic gonadotropin test and others. The autoimmunity test segment is further divided into immune globulin A test, immune globulin M test, immune globulin E test, and others.
End Users Outlook
On the basis of end users, the diagnostic reagents market has been divided into hospitals and clinics, research centers and laboratories, and others. The hospitals and clinics are currently generating maximum amount of revenue for this market. The number of patients that re being treated in hospitals and clinics are on higher side compared to other places.
Region Outlook
On the basis of region, the diagnostic reagents market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of the North America accounts for majority of money accumulated by this market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global diagnostic reagents market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global diagnostic reagents market are listed below:
- Agappe Diagnostics Ltd
- Agilent Technologies, Inc.
- BD
- bioMerieux SA
- Calbiotech
- DiaSorin S.p.A
- Hoffmann-La Roche Ltd
- Hipro Biotechnology Co. Ltd
- Lanyi Technology Group
- Lifecycle Biotechnologies
- Meriduan Bioscience, Inc.
- Randox Laboratories Ltd
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- Siemens Healthcare Private Limited
- Thermo Fisher Scientific, Inc
- Other Market Participants
Global Diagnostic Reagents Market
By Type
- In vivo diagnostic
- In vitro diagnostic
- Clinical Biochemical
- Immunodiagnostic reagents
- Molecular Diagnostic
By Application/ Test Type
- Cardiovascular Test
- Human Fatty Acid Binding Protein Test
- Cardiac Troponin Test
- Homocysteine Test
- Others
- Infection Test
- Renal Function Test
- Hemoglobin A1c Test
- Microalbumin Test
- Cystine Test
- Retinol Binding Protein Test
- Others
- Rheumatism Test
- Rheumatoid Factor Test
- Anti CCP
- Antistreptolysin O Test
- Gastric Function Test
- Pepsinogen I Test
- Pepsinogen II (PGII) Test
- Liver Test
- Prealbumin Blood Test
- Transferrin Blood Test
- Complement 4 Blood Test
- Others
- Hormone Test
- Thyroid Stimulating Hormone protein test
- Total Thyroxine Test
- Human Chorionic Gonadotropin Test
- Others
- Autoimmunity Test
- Immune Globulin A Test
- Immune Globulin M Test
- Immune Globulin E Test
- Others
- Others
By End Users
- Hospitals and Clinics
- Research centers and Laboratories
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 - 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Diagnostic Reagents Market
6.
Market
Synopsis:Â Diagnostic Reagents Market
7.
Diagnostic
Reagents Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Diagnostic Reagents Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Diagnostic Reagents Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Diagnostic Reagents
Market
8.
Global Diagnostic
Reagents Market Analysis and Forecasts, 2022 - 2030
8.1. Overview
8.1.1. Global Diagnostic Reagents Market Revenue
(US$ Mn)
8.2. Global Diagnostic Reagents Market Revenue
(US$ Mn) and Forecasts, By Type
8.2.1. In vivo diagnostic
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 - 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 - 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 - 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 - 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 - 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 - 2030
8.2.2. In vitro diagnostic (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
- 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Clinical Biochemical, Immunodiagnostic reagents , Molecular
Diagnostic )
8.2.2.1.
Clinical
Biochemical
8.2.2.2.
Immunodiagnostic
reagents
8.2.2.3.
Molecular
Diagnostic
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9.
Global Diagnostic
Reagents Market Analysis and Forecasts, 2022 - 2030
9.1. Overview
9.2. Global Diagnostic Reagents Market Revenue
(US$ Mn) and Forecasts, By Test Type
9.2.1. Cardiovascular Test (Definition, Market
Estimation and Penetration, 2015 - 2021, Market Estimation (2015 - 2021),
Market Forecast (2022 - 2030), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Human Fatty Acid Binding Protein Test, Cardiac Troponin
Test, Homocysteine Test, Others )
9.2.1.1.
Human
Fatty Acid Binding Protein Test
9.2.1.2.
Cardiac Troponin
Test
9.2.1.3.
Homocysteine
Test
9.2.1.4.
Others
9.2.2. Infection TestÂ
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 - 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 - 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 - 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 - 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 - 2030
9.2.3. Renal Function Test (Definition, Market
Estimation and Penetration, 2015 - 2021, Market Estimation (2015 - 2021),
Market Forecast (2022 - 2030), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Hemoglobin A1c Test, Microalbumin Test, Cystine
Test, Retinol Binding Protein Test, Others )
9.2.3.1.
Hemoglobin
A1c Test
9.2.3.2.
Microalbumin
Test
9.2.3.3.
Cystine
Test
9.2.3.4.
Retinol
Binding Protein Test
9.2.3.5.
Others
9.2.4. Rheumatism Test (Definition, Market
Estimation and Penetration, 2015 - 2021, Market Estimation (2015 - 2021),
Market Forecast (2022 - 2030), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Rheumatoid Factor Test, Anti CCP Test,
Antistreptolysin O Test )
9.2.4.1.
Rheumatoid
Factor Test
9.2.4.2.
Anti CCP
Test
9.2.4.3.
Antistreptolysin
O Test
9.2.5. Gastric Function Test (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
- 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Pepsinogen IÂ Test,
Pepsinogen II (PGII) Test )
9.2.5.1.
Pepsinogen
IÂ Test
9.2.5.2.
Pepsinogen
II (PGII) Test
9.2.6. Liver Test (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
- 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Prealbumin Blood Test, Transferrin Blood Test, Complement 4
Blood Test, Others)
9.2.6.1.
Prealbumin
Blood Test
9.2.6.2.
Transferrin
Blood Test
9.2.6.3.
Complement
4 Blood Test
9.2.6.4.
Others
9.2.7. Hormone Test (Definition, Market Estimation
and Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast
(2022 - 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Thyroid Stimulating Hormone protein test , Total Thyroxine Test,
Human Chorionic Gonadotropin Test, Others )
9.2.7.1.
Thyroid
Stimulating Hormone protein test
9.2.7.2.
Total
Thyroxine Test
9.2.7.3.
Human
Chorionic Gonadotropin Test
9.2.7.4.
Others
9.2.8. Autoimmunity Test (Definition, Market
Estimation and Penetration, 2015 - 2021, Market Estimation (2015 - 2021),
Market Forecast (2022 - 2030), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Immune Globulin A Test, Immune Globulin M Test,
Immune Globulin E Test, Others )
9.2.8.1.
Immune
Globulin A Test
9.2.8.2.
Immune
Globulin M Test
9.2.8.3.
Immune
Globulin E Test
9.2.8.4.
Others
9.2.9. Others
9.2.9.1.
Definition
9.2.9.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.9.3.
Market
Forecast, 2022 - 2030
9.2.9.4.
Compound
Annual Growth Rate (CAGR)
9.2.9.5.
Regional
Bifurcation
9.2.9.5.1.
North
America
9.2.9.5.1.1. Market Estimation, 2015 - 2021
9.2.9.5.1.2. Market Forecast, 2022 - 2030
9.2.9.5.2.
Europe
9.2.9.5.2.1. Market Estimation, 2015 - 2021
9.2.9.5.2.2. Market Forecast, 2022 - 2030
9.2.9.5.3.
Asia
Pacific
9.2.9.5.3.1. Market Estimation, 2015 - 2021
9.2.9.5.3.2. Market Forecast, 2022 - 2030
9.2.9.5.4.
Middle
East and Africa
9.2.9.5.4.1. Market Estimation, 2015 - 2021
9.2.9.5.4.2. Market Forecast, 2022 - 2030
9.2.9.5.5.
Latin
America
9.2.9.5.5.1. Market Estimation, 2015 - 2021
9.2.9.5.5.2. Market Forecast, 2022 - 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Test Type
10. Global Diagnostic Reagents Market Analysis
and Forecasts, 2022 - 2030
10.1. Overview
10.2. Global Diagnostic Reagents Market Revenue
(US$ Mn) and Forecasts, By End Users
10.2.1. Hospitals and clinics
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 - 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 - 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 - 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 - 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 - 2030
10.2.2. Research centers and Laboratories
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 - 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 - 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 - 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 - 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 - 2030
10.2.3. Others
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 - 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By End Users
11. North America Diagnostic Reagents Market
Analysis and Forecasts, 2022 - 2030
11.1. Overview
11.1.1. North America Diagnostic Reagents Market
Revenue (US$ Mn)
11.2. North America Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By Type
11.2.1. In vivo diagnostic
11.2.2. In vitro diagnostic
11.2.2.1.
Clinical
Biochemical
11.2.2.2.
Immunodiagnostic
reagents
11.2.2.3.
Molecular
Diagnostic
11.3. North America Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By Test Type
11.3.1. Cardiovascular Test
11.3.1.1.
Human
Fatty Acid Binding Protein Test
11.3.1.2.
Cardiac Troponin
Test
11.3.1.3.
Homocysteine
Test
11.3.1.4.
Others
11.3.2. Infection TestÂ
11.3.3. Renal Function Test
11.3.3.1.
Hemoglobin
A1c Test
11.3.3.2.
Microalbumin
Test
11.3.3.3.
Cystine
Test
11.3.3.4.
Retinol
Binding Protein Test
11.3.3.5.
Others
11.3.4. Rheumatism Test
11.3.4.1.
Rheumatoid
Factor Test
11.3.4.2.
Anti CCP
Test
11.3.4.3.
Antistreptolysin
O Test
11.3.5. Gastric Function Test
11.3.5.1.
Pepsinogen
IÂ Test
11.3.5.2.
Pepsinogen
II (PGII) Test
11.3.6. Liver Test
11.3.6.1.
Prealbumin
Blood Test
11.3.6.2.
Transferrin
Blood Test
11.3.6.3.
Complement
4 Blood Test
11.3.6.4.
Others
11.3.7. Hormone Test
11.3.7.1.
Thyroid
Stimulating Hormone protein test
11.3.7.2.
Total
Thyroxine Test
11.3.7.3.
Human
Chorionic Gonadotropin Test
11.3.7.4.
Others
11.3.8. Autoimmunity Test
11.3.8.1.
Immune
Globulin A Test
11.3.8.2.
Immune
Globulin M Test
11.3.8.3.
Immune
Globulin E Test
11.3.8.4.
Others
11.3.9. Others
11.4. North America Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By End Users
11.4.1. Hospitals and clinics
11.4.2. Research centers and Laboratories
11.4.3. Others
11.5. North America Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1.
U.S Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
11.5.1.1.1.
In vivo
diagnostic
11.5.1.1.2.
In vitro
diagnostic
11.5.1.1.2.1. Clinical Biochemical
11.5.1.1.2.2. Immunodiagnostic reagents
11.5.1.1.2.3. Molecular Diagnostic
11.5.1.2.
U.S Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
11.5.1.2.1.
Cardiovascular
Test
11.5.1.2.1.1. Human Fatty Acid Binding Protein Test
11.5.1.2.1.2. Cardiac Troponin Test
11.5.1.2.1.3. Homocysteine Test
11.5.1.2.1.4. Others
11.5.1.2.2.
Infection
TestÂ
11.5.1.2.3.
Renal
Function Test
11.5.1.2.3.1. Hemoglobin A1c Test
11.5.1.2.3.2. Microalbumin Test
11.5.1.2.3.3. Cystine Test
11.5.1.2.3.4. Retinol Binding Protein Test
11.5.1.2.3.5. Others
11.5.1.2.4.
Rheumatism
Test
11.5.1.2.4.1. Rheumatoid Factor Test
11.5.1.2.4.2. Anti CCP Test
11.5.1.2.4.3. Antistreptolysin O Test
11.5.1.2.5.
Gastric
Function Test
11.5.1.2.5.1. Pepsinogen IÂ
Test
11.5.1.2.5.2. Pepsinogen II (PGII) Test
11.5.1.2.6.
Liver
Test
11.5.1.2.6.1. Prealbumin Blood Test
11.5.1.2.6.2. Transferrin Blood Test
11.5.1.2.6.3. Complement 4 Blood Test
11.5.1.2.6.4. Others
11.5.1.2.7.
Hormone
Test
11.5.1.2.7.1. Thyroid Stimulating Hormone protein test
11.5.1.2.7.2. Total Thyroxine Test
11.5.1.2.7.3. Human Chorionic Gonadotropin Test
11.5.1.2.7.4. Others
11.5.1.2.8.
Autoimmunity
Test
11.5.1.2.8.1. Immune Globulin A Test
11.5.1.2.8.2. Immune Globulin M Test
11.5.1.2.8.3. Immune Globulin E Test
11.5.1.2.8.4. Others
11.5.1.2.9.
Others
11.5.1.3.
U.S Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.1.3.1.
Hospitals
and clinics
11.5.1.3.2.
Research
centers and Laboratories
11.5.1.3.3.
Others
11.5.2. Canada
11.5.2.1.
Canada Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
11.5.2.1.1.
In vivo
diagnostic
11.5.2.1.2.
In vitro
diagnostic
11.5.2.1.2.1. Clinical Biochemical
11.5.2.1.2.2. Immunodiagnostic reagents
11.5.2.1.2.3. Molecular Diagnostic
11.5.2.2.
Canada Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
11.5.2.2.1.
Cardiovascular
Test
11.5.2.2.1.1. Human Fatty Acid Binding Protein Test
11.5.2.2.1.2. Cardiac Troponin Test
11.5.2.2.1.3. Homocysteine Test
11.5.2.2.1.4. Others
11.5.2.2.2.
Infection
TestÂ
11.5.2.2.3.
Renal
Function Test
11.5.2.2.3.1. Hemoglobin A1c Test
11.5.2.2.3.2. Microalbumin Test
11.5.2.2.3.3. Cystine Test
11.5.2.2.3.4. Retinol Binding Protein Test
11.5.2.2.3.5. Others
11.5.2.2.4.
Rheumatism
Test
11.5.2.2.4.1. Rheumatoid Factor Test
11.5.2.2.4.2. Anti CCP Test
11.5.2.2.4.3. Antistreptolysin O Test
11.5.2.2.5.
Gastric
Function Test
11.5.2.2.5.1. Pepsinogen IÂ
Test
11.5.2.2.5.2. Pepsinogen II (PGII) Test
11.5.2.2.6.
Liver
Test
11.5.2.2.6.1. Prealbumin Blood Test
11.5.2.2.6.2. Transferrin Blood Test
11.5.2.2.6.3. Complement 4 Blood Test
11.5.2.2.6.4. Others
11.5.2.2.7.
Hormone
Test
11.5.2.2.7.1. Thyroid Stimulating Hormone protein test
11.5.2.2.7.2. Total Thyroxine Test
11.5.2.2.7.3. Human Chorionic Gonadotropin Test
11.5.2.2.7.4. Others
11.5.2.2.8.
Autoimmunity
Test
11.5.2.2.8.1. Immune Globulin A Test
11.5.2.2.8.2. Immune Globulin M Test
11.5.2.2.8.3. Immune Globulin E Test
11.5.2.2.8.4. Others
11.5.2.2.9.
Others
11.5.2.3.
Canada Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.2.3.1.
Hospitals
and clinics
11.5.2.3.2.
Research
centers and Laboratories
11.5.2.3.3.
Others
11.5.3. Mexico
11.5.3.1.
Mexico Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
11.5.3.1.1.
In vivo
diagnostic
11.5.3.1.2.
In vitro
diagnostic
11.5.3.1.2.1. Clinical Biochemical
11.5.3.1.2.2. Immunodiagnostic reagents
11.5.3.1.2.3. Molecular Diagnostic
11.5.3.2.
Mexico Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
11.5.3.2.1.
Cardiovascular
Test
11.5.3.2.1.1. Human Fatty Acid Binding Protein Test
11.5.3.2.1.2. Cardiac Troponin Test
11.5.3.2.1.3. Homocysteine Test
11.5.3.2.1.4. Others
11.5.3.2.2.
Infection
TestÂ
11.5.3.2.3.
Renal
Function Test
11.5.3.2.3.1. Hemoglobin A1c Test
11.5.3.2.3.2. Microalbumin Test
11.5.3.2.3.3. Cystine Test
11.5.3.2.3.4. Retinol Binding Protein Test
11.5.3.2.3.5. Others
11.5.3.2.4.
Rheumatism
Test
11.5.3.2.4.1. Rheumatoid Factor Test
11.5.3.2.4.2. Anti CCP Test
11.5.3.2.4.3. Antistreptolysin O Test
11.5.3.2.5.
Gastric
Function Test
11.5.3.2.5.1. Pepsinogen IÂ
Test
11.5.3.2.5.2. Pepsinogen II (PGII) Test
11.5.3.2.6.
Liver
Test
11.5.3.2.6.1. Prealbumin Blood Test
11.5.3.2.6.2. Transferrin Blood Test
11.5.3.2.6.3. Complement 4 Blood Test
11.5.3.2.6.4. Others
11.5.3.2.7.
Hormone
Test
11.5.3.2.7.1. Thyroid Stimulating Hormone protein test
11.5.3.2.7.2. Total Thyroxine Test
11.5.3.2.7.3. Human Chorionic Gonadotropin Test
11.5.3.2.7.4. Others
11.5.3.2.8.
Autoimmunity
Test
11.5.3.2.8.1. Immune Globulin A Test
11.5.3.2.8.2. Immune Globulin M Test
11.5.3.2.8.3. Immune Globulin E Test
11.5.3.2.8.4. Others
11.5.3.2.9.
Others
11.5.3.3.
Mexico Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.3.3.1.
Hospitals
and clinics
11.5.3.3.2.
Research
centers and Laboratories
11.5.3.3.3.
Others
11.5.4. Rest of North America
11.5.4.1.
Rest of
North America Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By
Type
11.5.4.1.1.
In vivo
diagnostic
11.5.4.1.2.
In vitro
diagnostic
11.5.4.1.2.1. Clinical Biochemical
11.5.4.1.2.2. Immunodiagnostic reagents
11.5.4.1.2.3. Molecular Diagnostic
11.5.4.2.
Rest of
North America Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By
Test Type
11.5.4.2.1.
Cardiovascular
Test
11.5.4.2.1.1. Human Fatty Acid Binding Protein Test
11.5.4.2.1.2. Cardiac Troponin Test
11.5.4.2.1.3. Homocysteine Test
11.5.4.2.1.4. Others
11.5.4.2.2.
Infection
TestÂ
11.5.4.2.3.
Renal
Function Test
11.5.4.2.3.1. Hemoglobin A1c Test
11.5.4.2.3.2. Microalbumin Test
11.5.4.2.3.3. Cystine Test
11.5.4.2.3.4. Retinol Binding Protein Test
11.5.4.2.3.5. Others
11.5.4.2.4.
Rheumatism
Test
11.5.4.2.4.1. Rheumatoid Factor Test
11.5.4.2.4.2. Anti CCP Test
11.5.4.2.4.3. Antistreptolysin O Test
11.5.4.2.5.
Gastric
Function Test
11.5.4.2.5.1. Pepsinogen IÂ
Test
11.5.4.2.5.2. Pepsinogen II (PGII) Test
11.5.4.2.6.
Liver
Test
11.5.4.2.6.1. Prealbumin Blood Test
11.5.4.2.6.2. Transferrin Blood Test
11.5.4.2.6.3. Complement 4 Blood Test
11.5.4.2.6.4. Others
11.5.4.2.7.
Hormone
Test
11.5.4.2.7.1. Thyroid Stimulating Hormone protein test
11.5.4.2.7.2. Total Thyroxine Test
11.5.4.2.7.3. Human Chorionic Gonadotropin Test
11.5.4.2.7.4. Others
11.5.4.2.8.
Autoimmunity
Test
11.5.4.2.8.1. Immune Globulin A Test
11.5.4.2.8.2. Immune Globulin M Test
11.5.4.2.8.3. Immune Globulin E Test
11.5.4.2.8.4. Others
11.5.4.2.9.
Others
11.5.4.3.
Rest of
North America Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End
Users
11.5.4.3.1.
Hospitals
and clinics
11.5.4.3.2.
Research
centers and Laboratories
11.5.4.3.3.
Others
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Type
11.6.3. By Test Type
11.6.4. By End Users
12. Europe Diagnostic Reagents Market Analysis
and Forecasts, 2022 - 2030
12.1. Overview
12.1.1. Europe Diagnostic Reagents Market Revenue
(US$ Mn)
12.2. Europe Diagnostic Reagents Market Revenue
(US$ Mn) and Forecasts, By Type
12.2.1. In vivo diagnostic
12.2.2. In vitro diagnostic
12.2.2.1.
Clinical
Biochemical
12.2.2.2.
Immunodiagnostic
reagents
12.2.2.3.
Molecular
Diagnostic
12.3. Europe Diagnostic Reagents Market Revenue
(US$ Mn) and Forecasts, By Test Type
12.3.1. Cardiovascular Test
12.3.1.1.
Human
Fatty Acid Binding Protein Test
12.3.1.2.
Cardiac Troponin
Test
12.3.1.3.
Homocysteine
Test
12.3.1.4.
Others
12.3.2. Infection TestÂ
12.3.3. Renal Function Test
12.3.3.1.
Hemoglobin
A1c Test
12.3.3.2.
Microalbumin
Test
12.3.3.3.
Cystine
Test
12.3.3.4.
Retinol
Binding Protein Test
12.3.3.5.
Others
12.3.4. Rheumatism Test
12.3.4.1.
Rheumatoid
Factor Test
12.3.4.2.
Anti CCP
Test
12.3.4.3.
Antistreptolysin
O Test
12.3.5. Gastric Function Test
12.3.5.1.
Pepsinogen
IÂ Test
12.3.5.2.
Pepsinogen
II (PGII) Test
12.3.6. Liver Test
12.3.6.1.
Prealbumin
Blood Test
12.3.6.2.
Transferrin
Blood Test
12.3.6.3.
Complement
4 Blood Test
12.3.6.4.
Others
12.3.7. Hormone Test
12.3.7.1.
Thyroid
Stimulating Hormone protein test
12.3.7.2.
Total
Thyroxine Test
12.3.7.3.
Human
Chorionic Gonadotropin Test
12.3.7.4.
Others
12.3.8. Autoimmunity Test
12.3.8.1.
Immune
Globulin A Test
12.3.8.2.
Immune
Globulin M Test
12.3.8.3.
Immune Globulin
E Test
12.3.8.4.
Others
12.3.9. Others
12.4. Europe Diagnostic Reagents Market Revenue
(US$ Mn) and Forecasts, By End Users
12.4.1. Hospitals and clinics
12.4.2. Research centers and Laboratories
12.4.3. Others
12.5. Europe Diagnostic Reagents Market Revenue
(US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1.
France Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
12.5.1.1.1.
In vivo
diagnostic
12.5.1.1.2.
In vitro
diagnostic
12.5.1.1.2.1. Clinical Biochemical
12.5.1.1.2.2. Immunodiagnostic reagents
12.5.1.1.2.3. Molecular Diagnostic
12.5.1.2.
France Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
12.5.1.2.1.
Cardiovascular
Test
12.5.1.2.1.1. Human Fatty Acid Binding Protein Test
12.5.1.2.1.2. Cardiac Troponin Test
12.5.1.2.1.3. Homocysteine Test
12.5.1.2.1.4. Others
12.5.1.2.2.
Infection
TestÂ
12.5.1.2.3.
Renal
Function Test
12.5.1.2.3.1. Hemoglobin A1c Test
12.5.1.2.3.2. Microalbumin Test
12.5.1.2.3.3. Cystine Test
12.5.1.2.3.4. Retinol Binding Protein Test
12.5.1.2.3.5. Others
12.5.1.2.4.
Rheumatism
Test
12.5.1.2.4.1. Rheumatoid Factor Test
12.5.1.2.4.2. Anti CCP Test
12.5.1.2.4.3. Antistreptolysin O Test
12.5.1.2.5.
Gastric
Function Test
12.5.1.2.5.1. Pepsinogen IÂ
Test
12.5.1.2.5.2. Pepsinogen II (PGII) Test
12.5.1.2.6.
Liver
Test
12.5.1.2.6.1. Prealbumin Blood Test
12.5.1.2.6.2. Transferrin Blood Test
12.5.1.2.6.3. Complement 4 Blood Test
12.5.1.2.6.4. Others
12.5.1.2.7.
Hormone
Test
12.5.1.2.7.1. Thyroid Stimulating Hormone protein test
12.5.1.2.7.2. Total Thyroxine Test
12.5.1.2.7.3. Human Chorionic Gonadotropin Test
12.5.1.2.7.4. Others
12.5.1.2.8.
Autoimmunity
Test
12.5.1.2.8.1. Immune Globulin A Test
12.5.1.2.8.2. Immune Globulin M Test
12.5.1.2.8.3. Immune Globulin E Test
12.5.1.2.8.4. Others
12.5.1.2.9.
Others
12.5.1.3.
France Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1.3.1.
Hospitals
and clinics
12.5.1.3.2.
Research
centers and Laboratories
12.5.1.3.3.
Others
12.5.2. The UK
12.5.2.1.
The UK Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
12.5.2.1.1.
In vivo
diagnostic
12.5.2.1.2.
In vitro
diagnostic
12.5.2.1.2.1. Clinical Biochemical
12.5.2.1.2.2. Immunodiagnostic reagents
12.5.2.1.2.3. Molecular Diagnostic
12.5.2.2.
The UK Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
12.5.2.2.1.
Cardiovascular
Test
12.5.2.2.1.1. Human Fatty Acid Binding Protein Test
12.5.2.2.1.2. Cardiac Troponin Test
12.5.2.2.1.3. Homocysteine Test
12.5.2.2.1.4. Others
12.5.2.2.2.
Infection
TestÂ
12.5.2.2.3.
Renal
Function Test
12.5.2.2.3.1. Hemoglobin A1c Test
12.5.2.2.3.2. Microalbumin Test
12.5.2.2.3.3. Cystine Test
12.5.2.2.3.4. Retinol Binding Protein Test
12.5.2.2.3.5. Others
12.5.2.2.4.
Rheumatism
Test
12.5.2.2.4.1. Rheumatoid Factor Test
12.5.2.2.4.2. Anti CCP Test
12.5.2.2.4.3. Antistreptolysin O Test
12.5.2.2.5.
Gastric
Function Test
12.5.2.2.5.1. Pepsinogen IÂ
Test
12.5.2.2.5.2. Pepsinogen II (PGII) Test
12.5.2.2.6.
Liver
Test
12.5.2.2.6.1. Prealbumin Blood Test
12.5.2.2.6.2. Transferrin Blood Test
12.5.2.2.6.3. Complement 4 Blood Test
12.5.2.2.6.4. Others
12.5.2.2.7.
Hormone
Test
12.5.2.2.7.1. Thyroid Stimulating Hormone protein test
12.5.2.2.7.2. Total Thyroxine Test
12.5.2.2.7.3. Human Chorionic Gonadotropin Test
12.5.2.2.7.4. Others
12.5.2.2.8.
Autoimmunity
Test
12.5.2.2.8.1. Immune Globulin A Test
12.5.2.2.8.2. Immune Globulin M Test
12.5.2.2.8.3. Immune Globulin E Test
12.5.2.2.8.4. Others
12.5.2.2.9.
Others
12.5.2.3.
The UK Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.2.3.1.
Hospitals
and clinics
12.5.2.3.2.
Research
centers and Laboratories
12.5.2.3.3.
Others
12.5.3. Spain
12.5.3.1.
Spain Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
12.5.3.1.1.
In vivo
diagnostic
12.5.3.1.2.
In vitro
diagnostic
12.5.3.1.2.1. Clinical Biochemical
12.5.3.1.2.2. Immunodiagnostic reagents
12.5.3.1.2.3. Molecular Diagnostic
12.5.3.2.
Spain Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
12.5.3.2.1.
Cardiovascular
Test
12.5.3.2.1.1. Human Fatty Acid Binding Protein Test
12.5.3.2.1.2. Cardiac Troponin Test
12.5.3.2.1.3. Homocysteine Test
12.5.3.2.1.4. Others
12.5.3.2.2.
Infection
TestÂ
12.5.3.2.3.
Renal
Function Test
12.5.3.2.3.1. Hemoglobin A1c Test
12.5.3.2.3.2. Microalbumin Test
12.5.3.2.3.3. Cystine Test
12.5.3.2.3.4. Retinol Binding Protein Test
12.5.3.2.3.5. Others
12.5.3.2.4.
Rheumatism
Test
12.5.3.2.4.1. Rheumatoid Factor Test
12.5.3.2.4.2. Anti CCP Test
12.5.3.2.4.3. Antistreptolysin O Test
12.5.3.2.5.
Gastric
Function Test
12.5.3.2.5.1. Pepsinogen IÂ
Test
12.5.3.2.5.2. Pepsinogen II (PGII) Test
12.5.3.2.6.
Liver
Test
12.5.3.2.6.1. Prealbumin Blood Test
12.5.3.2.6.2. Transferrin Blood Test
12.5.3.2.6.3. Complement 4 Blood Test
12.5.3.2.6.4. Others
12.5.3.2.7.
Hormone
Test
12.5.3.2.7.1. Thyroid Stimulating Hormone protein test
12.5.3.2.7.2. Total Thyroxine Test
12.5.3.2.7.3. Human Chorionic Gonadotropin Test
12.5.3.2.7.4. Others
12.5.3.2.8.
Autoimmunity
Test
12.5.3.2.8.1. Immune Globulin A Test
12.5.3.2.8.2. Immune Globulin M Test
12.5.3.2.8.3. Immune Globulin E Test
12.5.3.2.8.4. Others
12.5.3.2.9.
Others
12.5.3.3.
Spain Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.3.3.1.
Hospitals
and clinics
12.5.3.3.2.
Research
centers and Laboratories
12.5.3.3.3.
Others
12.5.4. Germany
12.5.4.1.
Germany Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
12.5.4.1.1.
In vivo
diagnostic
12.5.4.1.2.
In vitro
diagnostic
12.5.4.1.2.1. Clinical Biochemical
12.5.4.1.2.2. Immunodiagnostic reagents
12.5.4.1.2.3. Molecular Diagnostic
12.5.4.2.
Germany Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
12.5.4.2.1.
Cardiovascular
Test
12.5.4.2.1.1. Human Fatty Acid Binding Protein Test
12.5.4.2.1.2. Cardiac Troponin Test
12.5.4.2.1.3. Homocysteine Test
12.5.4.2.1.4. Others
12.5.4.2.2.
Infection
TestÂ
12.5.4.2.3.
Renal
Function Test
12.5.4.2.3.1. Hemoglobin A1c Test
12.5.4.2.3.2. Microalbumin Test
12.5.4.2.3.3. Cystine Test
12.5.4.2.3.4. Retinol Binding Protein Test
12.5.4.2.3.5. Others
12.5.4.2.4.
Rheumatism
Test
12.5.4.2.4.1. Rheumatoid Factor Test
12.5.4.2.4.2. Anti CCP Test
12.5.4.2.4.3. Antistreptolysin O Test
12.5.4.2.5.
Gastric
Function Test
12.5.4.2.5.1. Pepsinogen IÂ
Test
12.5.4.2.5.2. Pepsinogen II (PGII) Test
12.5.4.2.6.
Liver
Test
12.5.4.2.6.1. Prealbumin Blood Test
12.5.4.2.6.2. Transferrin Blood Test
12.5.4.2.6.3. Complement 4 Blood Test
12.5.4.2.6.4. Others
12.5.4.2.7.
Hormone
Test
12.5.4.2.7.1. Thyroid Stimulating Hormone protein test
12.5.4.2.7.2. Total Thyroxine Test
12.5.4.2.7.3. Human Chorionic Gonadotropin Test
12.5.4.2.7.4. Others
12.5.4.2.8.
Autoimmunity
Test
12.5.4.2.8.1. Immune Globulin A Test
12.5.4.2.8.2. Immune Globulin M Test
12.5.4.2.8.3. Immune Globulin E Test
12.5.4.2.8.4. Others
12.5.4.2.9.
Others
12.5.4.3.
Germany Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.4.3.1.
Hospitals
and clinics
12.5.4.3.2.
Research
centers and Laboratories
12.5.4.3.3.
Others
12.5.5. Italy
12.5.5.1.
Italy Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
12.5.5.1.1.
In vivo
diagnostic
12.5.5.1.2.
In vitro
diagnostic
12.5.5.1.2.1. Clinical Biochemical
12.5.5.1.2.2. Immunodiagnostic reagents
12.5.5.1.2.3. Molecular Diagnostic
12.5.5.2.
Italy Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
12.5.5.2.1.
Cardiovascular
Test
12.5.5.2.1.1. Human Fatty Acid Binding Protein Test
12.5.5.2.1.2. Cardiac Troponin Test
12.5.5.2.1.3. Homocysteine Test
12.5.5.2.1.4. Others
12.5.5.2.2.
Infection
TestÂ
12.5.5.2.3.
Renal
Function Test
12.5.5.2.3.1. Hemoglobin A1c Test
12.5.5.2.3.2. Microalbumin Test
12.5.5.2.3.3. Cystine Test
12.5.5.2.3.4. Retinol Binding Protein Test
12.5.5.2.3.5. Others
12.5.5.2.4.
Rheumatism
Test
12.5.5.2.4.1. Rheumatoid Factor Test
12.5.5.2.4.2. Anti CCP Test
12.5.5.2.4.3. Antistreptolysin O Test
12.5.5.2.5.
Gastric
Function Test
12.5.5.2.5.1. Pepsinogen IÂ
Test
12.5.5.2.5.2. Pepsinogen II (PGII) Test
12.5.5.2.6.
Liver
Test
12.5.5.2.6.1. Prealbumin Blood Test
12.5.5.2.6.2. Transferrin Blood Test
12.5.5.2.6.3. Complement 4 Blood Test
12.5.5.2.6.4. Others
12.5.5.2.7.
Hormone
Test
12.5.5.2.7.1. Thyroid Stimulating Hormone protein test
12.5.5.2.7.2. Total Thyroxine Test
12.5.5.2.7.3. Human Chorionic Gonadotropin Test
12.5.5.2.7.4. Others
12.5.5.2.8.
Autoimmunity
Test
12.5.5.2.8.1. Immune Globulin A Test
12.5.5.2.8.2. Immune Globulin M Test
12.5.5.2.8.3. Immune Globulin E Test
12.5.5.2.8.4. Others
12.5.5.2.9.
Others
12.5.5.3.
Italy Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.5.3.1.
Hospitals
and clinics
12.5.5.3.2.
Research
centers and Laboratories
12.5.5.3.3.
Others
12.5.6. Nordic Countries
12.5.6.1.
Nordic
Countries Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
12.5.6.1.1.
In vivo
diagnostic
12.5.6.1.2.
In vitro
diagnostic
12.5.6.1.2.1. Clinical Biochemical
12.5.6.1.2.2. Immunodiagnostic reagents
12.5.6.1.2.3. Molecular Diagnostic
12.5.6.2.
Nordic
Countries Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test
Type
12.5.6.2.1.
Cardiovascular
Test
12.5.6.2.1.1. Human Fatty Acid Binding Protein Test
12.5.6.2.1.2. Cardiac Troponin Test
12.5.6.2.1.3. Homocysteine Test
12.5.6.2.1.4. Others
12.5.6.2.2.
Infection
TestÂ
12.5.6.2.3.
Renal
Function Test
12.5.6.2.3.1. Hemoglobin A1c Test
12.5.6.2.3.2. Microalbumin Test
12.5.6.2.3.3. Cystine Test
12.5.6.2.3.4. Retinol Binding Protein Test
12.5.6.2.3.5. Others
12.5.6.2.4.
Rheumatism
Test
12.5.6.2.4.1. Rheumatoid Factor Test
12.5.6.2.4.2. Anti CCP Test
12.5.6.2.4.3. Antistreptolysin O Test
12.5.6.2.5.
Gastric
Function Test
12.5.6.2.5.1. Pepsinogen IÂ
Test
12.5.6.2.5.2. Pepsinogen II (PGII) Test
12.5.6.2.6.
Liver
Test
12.5.6.2.6.1. Prealbumin Blood Test
12.5.6.2.6.2. Transferrin Blood Test
12.5.6.2.6.3. Complement 4 Blood Test
12.5.6.2.6.4. Others
12.5.6.2.7.
Hormone
Test
12.5.6.2.7.1. Thyroid Stimulating Hormone protein test
12.5.6.2.7.2. Total Thyroxine Test
12.5.6.2.7.3. Human Chorionic Gonadotropin Test
12.5.6.2.7.4. Others
12.5.6.2.8.
Autoimmunity
Test
12.5.6.2.8.1. Immune Globulin A Test
12.5.6.2.8.2. Immune Globulin M Test
12.5.6.2.8.3. Immune Globulin E Test
12.5.6.2.8.4. Others
12.5.6.2.9.
Others
12.5.6.3.
Nordic
Countries Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End
Users
12.5.6.3.1.
Hospitals
and clinics
12.5.6.3.2.
Research
centers and Laboratories
12.5.6.3.3.
Others
12.5.6.4.
Nordic
Countries Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1.
Denmark
12.5.6.4.2.
Finland
12.5.6.4.3.
Iceland
12.5.6.4.4.
Sweden
12.5.6.4.5.
Norway
12.5.7. Benelux Union
12.5.7.1.
Benelux
Union Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
12.5.7.1.1.
In vivo
diagnostic
12.5.7.1.2.
In vitro
diagnostic
12.5.7.1.2.1. Clinical Biochemical
12.5.7.1.2.2. Immunodiagnostic reagents
12.5.7.1.2.3. Molecular Diagnostic
12.5.7.2.
Benelux
Union Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
12.5.7.2.1.
Cardiovascular
Test
12.5.7.2.1.1. Human Fatty Acid Binding Protein Test
12.5.7.2.1.2. Cardiac Troponin Test
12.5.7.2.1.3. Homocysteine Test
12.5.7.2.1.4. Others
12.5.7.2.2.
Infection
TestÂ
12.5.7.2.3.
Renal
Function Test
12.5.7.2.3.1. Hemoglobin A1c Test
12.5.7.2.3.2. Microalbumin Test
12.5.7.2.3.3. Cystine Test
12.5.7.2.3.4. Retinol Binding Protein Test
12.5.7.2.3.5. Others
12.5.7.2.4.
Rheumatism
Test
12.5.7.2.4.1. Rheumatoid Factor Test
12.5.7.2.4.2. Anti CCP Test
12.5.7.2.4.3. Antistreptolysin O Test
12.5.7.2.5.
Gastric
Function Test
12.5.7.2.5.1. Pepsinogen IÂ
Test
12.5.7.2.5.2. Pepsinogen II (PGII) Test
12.5.7.2.6.
Liver
Test
12.5.7.2.6.1. Prealbumin Blood Test
12.5.7.2.6.2. Transferrin Blood Test
12.5.7.2.6.3. Complement 4 Blood Test
12.5.7.2.6.4. Others
12.5.7.2.7.
Hormone
Test
12.5.7.2.7.1. Thyroid Stimulating Hormone protein test
12.5.7.2.7.2. Total Thyroxine Test
12.5.7.2.7.3. Human Chorionic Gonadotropin Test
12.5.7.2.7.4. Others
12.5.7.2.8.
Autoimmunity
Test
12.5.7.2.8.1. Immune Globulin A Test
12.5.7.2.8.2. Immune Globulin M Test
12.5.7.2.8.3. Immune Globulin E Test
12.5.7.2.8.4. Others
12.5.7.2.9.
Others
12.5.7.3.
Benelux
Union Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.7.3.1.
Hospitals
and clinics
12.5.7.3.2.
Research
centers and Laboratories
12.5.7.3.3.
Others
12.5.7.4.
Benelux
Union Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1.
Belgium
12.5.7.4.2.
The
Netherlands
12.5.7.4.3.
Luxembourg
12.5.8. Rest of Europe
12.5.8.1.
Rest of
Europe Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
12.5.8.1.1.
In vivo
diagnostic
12.5.8.1.2.
In vitro
diagnostic
12.5.8.1.2.1. Clinical Biochemical
12.5.8.1.2.2. Immunodiagnostic reagents
12.5.8.1.2.3. Molecular Diagnostic
12.5.8.2.
Rest of
Europe Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
12.5.8.2.1.
Cardiovascular
Test
12.5.8.2.1.1. Human Fatty Acid Binding Protein Test
12.5.8.2.1.2. Cardiac Troponin Test
12.5.8.2.1.3. Homocysteine Test
12.5.8.2.1.4. Others
12.5.8.2.2.
Infection
TestÂ
12.5.8.2.3.
Renal
Function Test
12.5.8.2.3.1. Hemoglobin A1c Test
12.5.8.2.3.2. Microalbumin Test
12.5.8.2.3.3. Cystine Test
12.5.8.2.3.4. Retinol Binding Protein Test
12.5.8.2.3.5. Others
12.5.8.2.4.
Rheumatism
Test
12.5.8.2.4.1. Rheumatoid Factor Test
12.5.8.2.4.2. Anti CCP Test
12.5.8.2.4.3. Antistreptolysin O Test
12.5.8.2.5.
Gastric
Function Test
12.5.8.2.5.1. Pepsinogen IÂ
Test
12.5.8.2.5.2. Pepsinogen II (PGII) Test
12.5.8.2.6.
Liver
Test
12.5.8.2.6.1. Prealbumin Blood Test
12.5.8.2.6.2. Transferrin Blood Test
12.5.8.2.6.3. Complement 4 Blood Test
12.5.8.2.6.4. Others
12.5.8.2.7.
Hormone
Test
12.5.8.2.7.1. Thyroid Stimulating Hormone protein test
12.5.8.2.7.2. Total Thyroxine Test
12.5.8.2.7.3. Human Chorionic Gonadotropin Test
12.5.8.2.7.4. Others
12.5.8.2.8.
Autoimmunity
Test
12.5.8.2.8.1. Immune Globulin A Test
12.5.8.2.8.2. Immune Globulin M Test
12.5.8.2.8.3. Immune Globulin E Test
12.5.8.2.8.4. Others
12.5.8.2.9.
Others
12.5.8.3.
Rest of
Europe Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.8.3.1.
Hospitals
and clinics
12.5.8.3.2.
Research
centers and Laboratories
12.5.8.3.3.
Others
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Type
12.6.3. By Test Type
12.6.4. By End Users
13. Asia Pacific Diagnostic Reagents Market
Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Asia Pacific Diagnostic Reagents Market
Revenue (US$ Mn)
13.2. Asia Pacific Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By Type
13.2.1. In vivo diagnostic
13.2.2. In vitro diagnostic
13.2.2.1.
Clinical
Biochemical
13.2.2.2.
Immunodiagnostic
reagents
13.2.2.3.
Molecular
Diagnostic
13.3. Asia Pacific Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By Test Type
13.3.1. Cardiovascular Test
13.3.1.1.
Human
Fatty Acid Binding Protein Test
13.3.1.2.
Cardiac Troponin
Test
13.3.1.3.
Homocysteine
Test
13.3.1.4.
Others
13.3.2. Infection TestÂ
13.3.3. Renal Function Test
13.3.3.1.
Hemoglobin
A1c Test
13.3.3.2.
Microalbumin
Test
13.3.3.3.
Cystine
Test
13.3.3.4.
Retinol
Binding Protein Test
13.3.3.5.
Others
13.3.4. Rheumatism Test
13.3.4.1.
Rheumatoid
Factor Test
13.3.4.2.
Anti CCP
Test
13.3.4.3.
Antistreptolysin
O Test
13.3.5. Gastric Function Test
13.3.5.1.
Pepsinogen
IÂ Test
13.3.5.2.
Pepsinogen
II (PGII) Test
13.3.6. Liver Test
13.3.6.1.
Prealbumin
Blood Test
13.3.6.2.
Transferrin
Blood Test
13.3.6.3.
Complement
4 Blood Test
13.3.6.4.
Others
13.3.7. Hormone Test
13.3.7.1.
Thyroid
Stimulating Hormone protein test
13.3.7.2.
Total
Thyroxine Test
13.3.7.3.
Human
Chorionic Gonadotropin Test
13.3.7.4.
Others
13.3.8. Autoimmunity Test
13.3.8.1.
Immune
Globulin A Test
13.3.8.2.
Immune
Globulin M Test
13.3.8.3.
Immune Globulin
E Test
13.3.8.4.
Others
13.3.9. Others
13.4. Asia Pacific Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By End Users
13.4.1. Hospitals and clinics
13.4.2. Research centers and Laboratories
13.4.3. Others
13.5. Asia Pacific Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1.
China Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
13.5.1.1.1.
In vivo
diagnostic
13.5.1.1.2.
In vitro
diagnostic
13.5.1.1.2.1. Clinical Biochemical
13.5.1.1.2.2. Immunodiagnostic reagents
13.5.1.1.2.3. Molecular Diagnostic
13.5.1.2.
China Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
13.5.1.2.1.
Cardiovascular
Test
13.5.1.2.1.1. Human Fatty Acid Binding Protein Test
13.5.1.2.1.2. Cardiac Troponin Test
13.5.1.2.1.3. Homocysteine Test
13.5.1.2.1.4. Others
13.5.1.2.2.
Infection
TestÂ
13.5.1.2.3.
Renal
Function Test
13.5.1.2.3.1. Hemoglobin A1c Test
13.5.1.2.3.2. Microalbumin Test
13.5.1.2.3.3. Cystine Test
13.5.1.2.3.4. Retinol Binding Protein Test
13.5.1.2.3.5. Others
13.5.1.2.4.
Rheumatism
Test
13.5.1.2.4.1. Rheumatoid Factor Test
13.5.1.2.4.2. Anti CCP Test
13.5.1.2.4.3. Antistreptolysin O Test
13.5.1.2.5.
Gastric
Function Test
13.5.1.2.5.1. Pepsinogen IÂ
Test
13.5.1.2.5.2. Pepsinogen II (PGII) Test
13.5.1.2.6.
Liver
Test
13.5.1.2.6.1. Prealbumin Blood Test
13.5.1.2.6.2. Transferrin Blood Test
13.5.1.2.6.3. Complement 4 Blood Test
13.5.1.2.6.4. Others
13.5.1.2.7.
Hormone
Test
13.5.1.2.7.1. Thyroid Stimulating Hormone protein test
13.5.1.2.7.2. Total Thyroxine Test
13.5.1.2.7.3. Human Chorionic Gonadotropin Test
13.5.1.2.7.4. Others
13.5.1.2.8.
Autoimmunity
Test
13.5.1.2.8.1. Immune Globulin A Test
13.5.1.2.8.2. Immune Globulin M Test
13.5.1.2.8.3. Immune Globulin E Test
13.5.1.2.8.4. Others
13.5.1.2.9.
Others
13.5.1.3.
China Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1.3.1.
Hospitals
and clinics
13.5.1.3.2.
Research
centers and Laboratories
13.5.1.3.3.
Others
13.5.2. Japan
13.5.2.1.
Japan Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
13.5.2.1.1.
In vivo
diagnostic
13.5.2.1.2.
In vitro
diagnostic
13.5.2.1.2.1. Clinical Biochemical
13.5.2.1.2.2. Immunodiagnostic reagents
13.5.2.1.2.3. Molecular Diagnostic
13.5.2.2.
Japan Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
13.5.2.2.1.
Cardiovascular
Test
13.5.2.2.1.1. Human Fatty Acid Binding Protein Test
13.5.2.2.1.2. Cardiac Troponin Test
13.5.2.2.1.3. Homocysteine Test
13.5.2.2.1.4. Others
13.5.2.2.2.
Infection
TestÂ
13.5.2.2.3.
Renal Function
Test
13.5.2.2.3.1. Hemoglobin A1c Test
13.5.2.2.3.2. Microalbumin Test
13.5.2.2.3.3. Cystine Test
13.5.2.2.3.4. Retinol Binding Protein Test
13.5.2.2.3.5. Others
13.5.2.2.4.
Rheumatism
Test
13.5.2.2.4.1. Rheumatoid Factor Test
13.5.2.2.4.2. Anti CCP Test
13.5.2.2.4.3. Antistreptolysin O Test
13.5.2.2.5.
Gastric
Function Test
13.5.2.2.5.1. Pepsinogen IÂ
Test
13.5.2.2.5.2. Pepsinogen II (PGII) Test
13.5.2.2.6.
Liver Test
13.5.2.2.6.1. Prealbumin Blood Test
13.5.2.2.6.2. Transferrin Blood Test
13.5.2.2.6.3. Complement 4 Blood Test
13.5.2.2.6.4. Others
13.5.2.2.7.
Hormone
Test
13.5.2.2.7.1. Thyroid Stimulating Hormone protein test
13.5.2.2.7.2. Total Thyroxine Test
13.5.2.2.7.3. Human Chorionic Gonadotropin Test
13.5.2.2.7.4. Others
13.5.2.2.8.
Autoimmunity
Test
13.5.2.2.8.1. Immune Globulin A Test
13.5.2.2.8.2. Immune Globulin M Test
13.5.2.2.8.3. Immune Globulin E Test
13.5.2.2.8.4. Others
13.5.2.2.9.
Others
13.5.2.3.
Japan Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.2.3.1.
Hospitals
and clinics
13.5.2.3.2.
Research
centers and Laboratories
13.5.2.3.3.
Others
13.5.3. India
13.5.3.1.
India Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
13.5.3.1.1.
In vivo
diagnostic
13.5.3.1.2.
In vitro
diagnostic
13.5.3.1.2.1. Clinical Biochemical
13.5.3.1.2.2. Immunodiagnostic reagents
13.5.3.1.2.3. Molecular Diagnostic
13.5.3.2.
India Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
13.5.3.2.1.
Cardiovascular
Test
13.5.3.2.1.1. Human Fatty Acid Binding Protein Test
13.5.3.2.1.2. Cardiac Troponin Test
13.5.3.2.1.3. Homocysteine Test
13.5.3.2.1.4. Others
13.5.3.2.2.
Infection
TestÂ
13.5.3.2.3.
Renal
Function Test
13.5.3.2.3.1. Hemoglobin A1c Test
13.5.3.2.3.2. Microalbumin Test
13.5.3.2.3.3. Cystine Test
13.5.3.2.3.4. Retinol Binding Protein Test
13.5.3.2.3.5. Others
13.5.3.2.4.
Rheumatism
Test
13.5.3.2.4.1. Rheumatoid Factor Test
13.5.3.2.4.2. Anti CCP Test
13.5.3.2.4.3. Antistreptolysin O Test
13.5.3.2.5.
Gastric
Function Test
13.5.3.2.5.1. Pepsinogen IÂ
Test
13.5.3.2.5.2. Pepsinogen II (PGII) Test
13.5.3.2.6.
Liver
Test
13.5.3.2.6.1. Prealbumin Blood Test
13.5.3.2.6.2. Transferrin Blood Test
13.5.3.2.6.3. Complement 4 Blood Test
13.5.3.2.6.4. Others
13.5.3.2.7.
Hormone
Test
13.5.3.2.7.1. Thyroid Stimulating Hormone protein test
13.5.3.2.7.2. Total Thyroxine Test
13.5.3.2.7.3. Human Chorionic Gonadotropin Test
13.5.3.2.7.4. Others
13.5.3.2.8.
Autoimmunity
Test
13.5.3.2.8.1. Immune Globulin A Test
13.5.3.2.8.2. Immune Globulin M Test
13.5.3.2.8.3. Immune Globulin E Test
13.5.3.2.8.4. Others
13.5.3.2.9.
Others
13.5.3.3.
India Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.3.3.1.
Hospitals
and clinics
13.5.3.3.2.
Research
centers and Laboratories
13.5.3.3.3.
Others
13.5.4. New Zealand
13.5.4.1.
New
Zealand Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
13.5.4.1.1.
In vivo
diagnostic
13.5.4.1.2.
In vitro
diagnostic
13.5.4.1.2.1. Clinical Biochemical
13.5.4.1.2.2. Immunodiagnostic reagents
13.5.4.1.2.3. Molecular Diagnostic
13.5.4.2.
New
Zealand Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
13.5.4.2.1.
Cardiovascular
Test
13.5.4.2.1.1. Human Fatty Acid Binding Protein Test
13.5.4.2.1.2. Cardiac Troponin Test
13.5.4.2.1.3. Homocysteine Test
13.5.4.2.1.4. Others
13.5.4.2.2.
Infection
TestÂ
13.5.4.2.3.
Renal
Function Test
13.5.4.2.3.1. Hemoglobin A1c Test
13.5.4.2.3.2. Microalbumin Test
13.5.4.2.3.3. Cystine Test
13.5.4.2.3.4. Retinol Binding Protein Test
13.5.4.2.3.5. Others
13.5.4.2.4.
Rheumatism
Test
13.5.4.2.4.1. Rheumatoid Factor Test
13.5.4.2.4.2. Anti CCP Test
13.5.4.2.4.3. Antistreptolysin O Test
13.5.4.2.5.
Gastric
Function Test
13.5.4.2.5.1. Pepsinogen IÂ
Test
13.5.4.2.5.2. Pepsinogen II (PGII) Test
13.5.4.2.6.
Liver
Test
13.5.4.2.6.1. Prealbumin Blood Test
13.5.4.2.6.2. Transferrin Blood Test
13.5.4.2.6.3. Complement 4 Blood Test
13.5.4.2.6.4. Others
13.5.4.2.7.
Hormone
Test
13.5.4.2.7.1. Thyroid Stimulating Hormone protein test
13.5.4.2.7.2. Total Thyroxine Test
13.5.4.2.7.3. Human Chorionic Gonadotropin Test
13.5.4.2.7.4. Others
13.5.4.2.8.
Autoimmunity
Test
13.5.4.2.8.1. Immune Globulin A Test
13.5.4.2.8.2. Immune Globulin M Test
13.5.4.2.8.3. Immune Globulin E Test
13.5.4.2.8.4. Others
13.5.4.2.9.
Others
13.5.4.3.
New
Zealand Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.4.3.1.
Hospitals
and clinics
13.5.4.3.2.
Research
centers and Laboratories
13.5.4.3.3.
Others
13.5.5. Australia
13.5.5.1.
Australia
Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
13.5.5.1.1.
In vivo
diagnostic
13.5.5.1.2.
In vitro
diagnostic
13.5.5.1.2.1. Clinical Biochemical
13.5.5.1.2.2. Immunodiagnostic reagents
13.5.5.1.2.3. Molecular Diagnostic
13.5.5.2.
Australia
Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
13.5.5.2.1.
Cardiovascular
Test
13.5.5.2.1.1. Human Fatty Acid Binding Protein Test
13.5.5.2.1.2. Cardiac Troponin Test
13.5.5.2.1.3. Homocysteine Test
13.5.5.2.1.4. Others
13.5.5.2.2.
Infection
TestÂ
13.5.5.2.3.
Renal
Function Test
13.5.5.2.3.1. Hemoglobin A1c Test
13.5.5.2.3.2. Microalbumin Test
13.5.5.2.3.3. Cystine Test
13.5.5.2.3.4. Retinol Binding Protein Test
13.5.5.2.3.5. Others
13.5.5.2.4.
Rheumatism
Test
13.5.5.2.4.1. Rheumatoid Factor Test
13.5.5.2.4.2. Anti CCP Test
13.5.5.2.4.3. Antistreptolysin O Test
13.5.5.2.5.
Gastric
Function Test
13.5.5.2.5.1. Pepsinogen IÂ
Test
13.5.5.2.5.2. Pepsinogen II (PGII) Test
13.5.5.2.6.
Liver
Test
13.5.5.2.6.1. Prealbumin Blood Test
13.5.5.2.6.2. Transferrin Blood Test
13.5.5.2.6.3. Complement 4 Blood Test
13.5.5.2.6.4. Others
13.5.5.2.7.
Hormone
Test
13.5.5.2.7.1. Thyroid Stimulating Hormone protein test
13.5.5.2.7.2. Total Thyroxine Test
13.5.5.2.7.3. Human Chorionic Gonadotropin Test
13.5.5.2.7.4. Others
13.5.5.2.8.
Autoimmunity
Test
13.5.5.2.8.1. Immune Globulin A Test
13.5.5.2.8.2. Immune Globulin M Test
13.5.5.2.8.3. Immune Globulin E Test
13.5.5.2.8.4. Others
13.5.5.2.9.
Others
13.5.5.3.
Australia
Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.5.3.1.
Hospitals
and clinics
13.5.5.3.2.
Research
centers and Laboratories
13.5.5.3.3.
Others
13.5.6. South Korea
13.5.6.1.
South
Korea Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
13.5.6.1.1.
In vivo
diagnostic
13.5.6.1.2.
In vitro
diagnostic
13.5.6.1.2.1. Clinical Biochemical
13.5.6.1.2.2. Immunodiagnostic reagents
13.5.6.1.2.3. Molecular Diagnostic
13.5.6.2.
South
Korea Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
13.5.6.2.1.
Cardiovascular
Test
13.5.6.2.1.1. Human Fatty Acid Binding Protein Test
13.5.6.2.1.2. Cardiac Troponin Test
13.5.6.2.1.3. Homocysteine Test
13.5.6.2.1.4. Others
13.5.6.2.2.
Infection
TestÂ
13.5.6.2.3.
Renal
Function Test
13.5.6.2.3.1. Hemoglobin A1c Test
13.5.6.2.3.2. Microalbumin Test
13.5.6.2.3.3. Cystine Test
13.5.6.2.3.4. Retinol Binding Protein Test
13.5.6.2.3.5. Others
13.5.6.2.4.
Rheumatism
Test
13.5.6.2.4.1. Rheumatoid Factor Test
13.5.6.2.4.2. Anti CCP Test
13.5.6.2.4.3. Antistreptolysin O Test
13.5.6.2.5.
Gastric
Function Test
13.5.6.2.5.1. Pepsinogen IÂ
Test
13.5.6.2.5.2. Pepsinogen II (PGII) Test
13.5.6.2.6.
Liver
Test
13.5.6.2.6.1. Prealbumin Blood Test
13.5.6.2.6.2. Transferrin Blood Test
13.5.6.2.6.3. Complement 4 Blood Test
13.5.6.2.6.4. Others
13.5.6.2.7.
Hormone
Test
13.5.6.2.7.1. Thyroid Stimulating Hormone protein test
13.5.6.2.7.2. Total Thyroxine Test
13.5.6.2.7.3. Human Chorionic Gonadotropin Test
13.5.6.2.7.4. Others
13.5.6.2.8.
Autoimmunity
Test
13.5.6.2.8.1. Immune Globulin A Test
13.5.6.2.8.2. Immune Globulin M Test
13.5.6.2.8.3. Immune Globulin E Test
13.5.6.2.8.4. Others
13.5.6.2.9.
Others
13.5.6.3.
South
Korea Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.6.3.1.
Hospitals
and clinics
13.5.6.3.2.
Research
centers and Laboratories
13.5.6.3.3.
Others
13.5.7. Southeast Asia
13.5.7.1.
Southeast
Asia Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
13.5.7.1.1.
In vivo
diagnostic
13.5.7.1.2.
In vitro
diagnostic
13.5.7.1.2.1. Clinical Biochemical
13.5.7.1.2.2. Immunodiagnostic reagents
13.5.7.1.2.3. Molecular Diagnostic
13.5.7.2.
Southeast
Asia Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
13.5.7.2.1.
Cardiovascular
Test
13.5.7.2.1.1. Human Fatty Acid Binding Protein Test
13.5.7.2.1.2. Cardiac Troponin Test
13.5.7.2.1.3. Homocysteine Test
13.5.7.2.1.4. Others
13.5.7.2.2.
Infection
TestÂ
13.5.7.2.3.
Renal
Function Test
13.5.7.2.3.1. Hemoglobin A1c Test
13.5.7.2.3.2. Microalbumin Test
13.5.7.2.3.3. Cystine Test
13.5.7.2.3.4. Retinol Binding Protein Test
13.5.7.2.3.5. Others
13.5.7.2.4.
Rheumatism
Test
13.5.7.2.4.1. Rheumatoid Factor Test
13.5.7.2.4.2. Anti CCP Test
13.5.7.2.4.3. Antistreptolysin O Test
13.5.7.2.5.
Gastric
Function Test
13.5.7.2.5.1. Pepsinogen IÂ
Test
13.5.7.2.5.2. Pepsinogen II (PGII) Test
13.5.7.2.6.
Liver
Test
13.5.7.2.6.1. Prealbumin Blood Test
13.5.7.2.6.2. Transferrin Blood Test
13.5.7.2.6.3. Complement 4 Blood Test
13.5.7.2.6.4. Others
13.5.7.2.7.
Hormone
Test
13.5.7.2.7.1. Thyroid Stimulating Hormone protein test
13.5.7.2.7.2. Total Thyroxine Test
13.5.7.2.7.3. Human Chorionic Gonadotropin Test
13.5.7.2.7.4. Others
13.5.7.2.8.
Autoimmunity
Test
13.5.7.2.8.1. Immune Globulin A Test
13.5.7.2.8.2. Immune Globulin M Test
13.5.7.2.8.3. Immune Globulin E Test
13.5.7.2.8.4. Others
13.5.7.2.9.
Others
13.5.7.3.
Southeast
Asia Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.7.3.1.
Hospitals
and clinics
13.5.7.3.2.
Research
centers and Laboratories
13.5.7.3.3.
Others
13.5.7.4.
Southeast
Asia Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1.
Indonesia
13.5.7.4.2.
Thailand
13.5.7.4.3.
Malaysia
13.5.7.4.4.
Singapore
13.5.7.4.5.
Rest of
Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1.
Rest of
Asia Pacific Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
13.5.8.1.1.
In vivo
diagnostic
13.5.8.1.2.
In vitro
diagnostic
13.5.8.1.2.1. Clinical Biochemical
13.5.8.1.2.2. Immunodiagnostic reagents
13.5.8.1.2.3. Molecular Diagnostic
13.5.8.2.
Rest of
Asia Pacific Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test
Type
13.5.8.2.1.
Cardiovascular
Test
13.5.8.2.1.1. Human Fatty Acid Binding Protein Test
13.5.8.2.1.2. Cardiac Troponin Test
13.5.8.2.1.3. Homocysteine Test
13.5.8.2.1.4. Others
13.5.8.2.2.
Infection
TestÂ
13.5.8.2.3.
Renal
Function Test
13.5.8.2.3.1. Hemoglobin A1c Test
13.5.8.2.3.2. Microalbumin Test
13.5.8.2.3.3. Cystine Test
13.5.8.2.3.4. Retinol Binding Protein Test
13.5.8.2.3.5. Others
13.5.8.2.4.
Rheumatism
Test
13.5.8.2.4.1. Rheumatoid Factor Test
13.5.8.2.4.2. Anti CCP Test
13.5.8.2.4.3. Antistreptolysin O Test
13.5.8.2.5.
Gastric
Function Test
13.5.8.2.5.1. Pepsinogen IÂ
Test
13.5.8.2.5.2. Pepsinogen II (PGII) Test
13.5.8.2.6.
Liver
Test
13.5.8.2.6.1. Prealbumin Blood Test
13.5.8.2.6.2. Transferrin Blood Test
13.5.8.2.6.3. Complement 4 Blood Test
13.5.8.2.6.4. Others
13.5.8.2.7.
Hormone
Test
13.5.8.2.7.1. Thyroid Stimulating Hormone protein test
13.5.8.2.7.2. Total Thyroxine Test
13.5.8.2.7.3. Human Chorionic Gonadotropin Test
13.5.8.2.7.4. Others
13.5.8.2.8.
Autoimmunity
Test
13.5.8.2.8.1. Immune Globulin A Test
13.5.8.2.8.2. Immune Globulin M Test
13.5.8.2.8.3. Immune Globulin E Test
13.5.8.2.8.4. Others
13.5.8.2.9.
Others
13.5.8.3.
Rest of
Asia Pacific Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End
Users
13.5.8.3.1.
Hospitals
and clinics
13.5.8.3.2.
Research
centers and Laboratories
13.5.8.3.3.
Others
13.6. Key Segment for Channeling Investments
13.6.1. By Country
13.6.2. By Type
13.6.3. By Test Type
13.6.4. By End Users
14. Middle East and Africa Diagnostic Reagents
Market Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Middle East and Africa Diagnostic Reagents
Market Revenue (US$ Mn)
14.2. Middle East and Africa Diagnostic Reagents
Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. In vivo diagnostic
14.2.2. In vitro diagnostic
14.2.2.1.
Clinical
Biochemical
14.2.2.2.
Immunodiagnostic
reagents
14.2.2.3.
Molecular
Diagnostic
14.3. Middle East and Africa Diagnostic Reagents
Market Revenue (US$ Mn) and Forecasts, By Test Type
14.3.1. Cardiovascular Test
14.3.1.1.
Human
Fatty Acid Binding Protein Test
14.3.1.2.
Cardiac Troponin
Test
14.3.1.3.
Homocysteine
Test
14.3.1.4.
Others
14.3.2. Infection TestÂ
14.3.3. Renal Function Test
14.3.3.1.
Hemoglobin
A1c Test
14.3.3.2.
Microalbumin
Test
14.3.3.3.
Cystine
Test
14.3.3.4.
Retinol
Binding Protein Test
14.3.3.5.
Others
14.3.4. Rheumatism Test
14.3.4.1.
Rheumatoid
Factor Test
14.3.4.2.
Anti CCP
Test
14.3.4.3.
Antistreptolysin
O Test
14.3.5. Gastric Function Test
14.3.5.1.
Pepsinogen
IÂ Test
14.3.5.2.
Pepsinogen
II (PGII) Test
14.3.6. Liver Test
14.3.6.1.
Prealbumin
Blood Test
14.3.6.2.
Transferrin
Blood Test
14.3.6.3.
Complement
4 Blood Test
14.3.6.4.
Others
14.3.7. Hormone Test
14.3.7.1.
Thyroid
Stimulating Hormone protein test
14.3.7.2.
Total
Thyroxine Test
14.3.7.3.
Human
Chorionic Gonadotropin Test
14.3.7.4.
Others
14.3.8. Autoimmunity Test
14.3.8.1.
Immune
Globulin A Test
14.3.8.2.
Immune
Globulin M Test
14.3.8.3.
Immune
Globulin E Test
14.3.8.4.
Others
14.3.9. Others
14.4. Middle East and Africa Diagnostic Reagents
Market Revenue (US$ Mn) and Forecasts, By End Users
14.4.1. Hospitals and clinics
14.4.2. Research centers and Laboratories
14.4.3. Others
14.5. Middle East and Africa Diagnostic Reagents
Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1. Saudi Arabia
14.5.1.1.
Saudi
Arabia Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
14.5.1.1.1.
In vivo
diagnostic
14.5.1.1.2.
In vitro
diagnostic
14.5.1.1.2.1. Clinical Biochemical
14.5.1.1.2.2. Immunodiagnostic reagents
14.5.1.1.2.3. Molecular Diagnostic
14.5.1.2.
Saudi
Arabia Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
14.5.1.2.1.
Cardiovascular
Test
14.5.1.2.1.1. Human Fatty Acid Binding Protein Test
14.5.1.2.1.2. Cardiac Troponin Test
14.5.1.2.1.3. Homocysteine Test
14.5.1.2.1.4. Others
14.5.1.2.2.
Infection
TestÂ
14.5.1.2.3.
Renal
Function Test
14.5.1.2.3.1. Hemoglobin A1c Test
14.5.1.2.3.2. Microalbumin Test
14.5.1.2.3.3. Cystine Test
14.5.1.2.3.4. Retinol Binding Protein Test
14.5.1.2.3.5. Others
14.5.1.2.4.
Rheumatism
Test
14.5.1.2.4.1. Rheumatoid Factor Test
14.5.1.2.4.2. Anti CCP Test
14.5.1.2.4.3. Antistreptolysin O Test
14.5.1.2.5.
Gastric
Function Test
14.5.1.2.5.1. Pepsinogen IÂ
Test
14.5.1.2.5.2. Pepsinogen II (PGII) Test
14.5.1.2.6.
Liver
Test
14.5.1.2.6.1. Prealbumin Blood Test
14.5.1.2.6.2. Transferrin Blood Test
14.5.1.2.6.3. Complement 4 Blood Test
14.5.1.2.6.4. Others
14.5.1.2.7.
Hormone
Test
14.5.1.2.7.1. Thyroid Stimulating Hormone protein test
14.5.1.2.7.2. Total Thyroxine Test
14.5.1.2.7.3. Human Chorionic Gonadotropin Test
14.5.1.2.7.4. Others
14.5.1.2.8.
Autoimmunity
Test
14.5.1.2.8.1. Immune Globulin A Test
14.5.1.2.8.2. Immune Globulin M Test
14.5.1.2.8.3. Immune Globulin E Test
14.5.1.2.8.4. Others
14.5.1.2.9.
Others
14.5.1.3.
Saudi
Arabia Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1.3.1.
Hospitals
and clinics
14.5.1.3.2.
Research
centers and Laboratories
14.5.1.3.3.
Others
14.5.2. UAE
14.5.2.1.
UAE Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
14.5.2.1.1.
In vivo
diagnostic
14.5.2.1.2.
In vitro
diagnostic
14.5.2.1.2.1. Clinical Biochemical
14.5.2.1.2.2. Immunodiagnostic reagents
14.5.2.1.2.3. Molecular Diagnostic
14.5.2.2.
UAE Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
14.5.2.2.1.
Cardiovascular
Test
14.5.2.2.1.1. Human Fatty Acid Binding Protein Test
14.5.2.2.1.2. Cardiac Troponin Test
14.5.2.2.1.3. Homocysteine Test
14.5.2.2.1.4. Others
14.5.2.2.2.
Infection
TestÂ
14.5.2.2.3.
Renal Function
Test
14.5.2.2.3.1. Hemoglobin A1c Test
14.5.2.2.3.2. Microalbumin Test
14.5.2.2.3.3. Cystine Test
14.5.2.2.3.4. Retinol Binding Protein Test
14.5.2.2.3.5. Others
14.5.2.2.4.
Rheumatism
Test
14.5.2.2.4.1. Rheumatoid Factor Test
14.5.2.2.4.2. Anti CCP Test
14.5.2.2.4.3. Antistreptolysin O Test
14.5.2.2.5.
Gastric
Function Test
14.5.2.2.5.1. Pepsinogen IÂ
Test
14.5.2.2.5.2. Pepsinogen II (PGII) Test
14.5.2.2.6.
Liver Test
14.5.2.2.6.1. Prealbumin Blood Test
14.5.2.2.6.2. Transferrin Blood Test
14.5.2.2.6.3. Complement 4 Blood Test
14.5.2.2.6.4. Others
14.5.2.2.7.
Hormone
Test
14.5.2.2.7.1. Thyroid Stimulating Hormone protein test
14.5.2.2.7.2. Total Thyroxine Test
14.5.2.2.7.3. Human Chorionic Gonadotropin Test
14.5.2.2.7.4. Others
14.5.2.2.8.
Autoimmunity
Test
14.5.2.2.8.1. Immune Globulin A Test
14.5.2.2.8.2. Immune Globulin M Test
14.5.2.2.8.3. Immune Globulin E Test
14.5.2.2.8.4. Others
14.5.2.2.9.
Others
14.5.2.3.
UAE Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.2.3.1.
Hospitals
and clinics
14.5.2.3.2.
Research
centers and Laboratories
14.5.2.3.3.
Others
14.5.3. Egypt
14.5.3.1.
Egypt Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
14.5.3.1.1.
In vivo
diagnostic
14.5.3.1.2.
In vitro
diagnostic
14.5.3.1.2.1. Clinical Biochemical
14.5.3.1.2.2. Immunodiagnostic reagents
14.5.3.1.2.3. Molecular Diagnostic
14.5.3.2.
Egypt Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
14.5.3.2.1.
Cardiovascular
Test
14.5.3.2.1.1. Human Fatty Acid Binding Protein Test
14.5.3.2.1.2. Cardiac Troponin Test
14.5.3.2.1.3. Homocysteine Test
14.5.3.2.1.4. Others
14.5.3.2.2.
Infection
TestÂ
14.5.3.2.3.
Renal
Function Test
14.5.3.2.3.1. Hemoglobin A1c Test
14.5.3.2.3.2. Microalbumin Test
14.5.3.2.3.3. Cystine Test
14.5.3.2.3.4. Retinol Binding Protein Test
14.5.3.2.3.5. Others
14.5.3.2.4.
Rheumatism
Test
14.5.3.2.4.1. Rheumatoid Factor Test
14.5.3.2.4.2. Anti CCP Test
14.5.3.2.4.3. Antistreptolysin O Test
14.5.3.2.5.
Gastric
Function Test
14.5.3.2.5.1. Pepsinogen IÂ
Test
14.5.3.2.5.2. Pepsinogen II (PGII) Test
14.5.3.2.6.
Liver
Test
14.5.3.2.6.1. Prealbumin Blood Test
14.5.3.2.6.2. Transferrin Blood Test
14.5.3.2.6.3. Complement 4 Blood Test
14.5.3.2.6.4. Others
14.5.3.2.7.
Hormone
Test
14.5.3.2.7.1. Thyroid Stimulating Hormone protein test
14.5.3.2.7.2. Total Thyroxine Test
14.5.3.2.7.3. Human Chorionic Gonadotropin Test
14.5.3.2.7.4. Others
14.5.3.2.8.
Autoimmunity
Test
14.5.3.2.8.1. Immune Globulin A Test
14.5.3.2.8.2. Immune Globulin M Test
14.5.3.2.8.3. Immune Globulin E Test
14.5.3.2.8.4. Others
14.5.3.2.9.
Others
14.5.3.3.
Egypt Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.3.3.1.
Hospitals
and clinics
14.5.3.3.2.
Research
centers and Laboratories
14.5.3.3.3.
Others
14.5.4. Kuwait
14.5.4.1.
Kuwait Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
14.5.4.1.1.
In vivo
diagnostic
14.5.4.1.2.
In vitro
diagnostic
14.5.4.1.2.1. Clinical Biochemical
14.5.4.1.2.2. Immunodiagnostic reagents
14.5.4.1.2.3. Molecular Diagnostic
14.5.4.2.
Kuwait Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
14.5.4.2.1.
Cardiovascular
Test
14.5.4.2.1.1. Human Fatty Acid Binding Protein Test
14.5.4.2.1.2. Cardiac Troponin Test
14.5.4.2.1.3. Homocysteine Test
14.5.4.2.1.4. Others
14.5.4.2.2.
Infection
TestÂ
14.5.4.2.3.
Renal
Function Test
14.5.4.2.3.1. Hemoglobin A1c Test
14.5.4.2.3.2. Microalbumin Test
14.5.4.2.3.3. Cystine Test
14.5.4.2.3.4. Retinol Binding Protein Test
14.5.4.2.3.5. Others
14.5.4.2.4.
Rheumatism
Test
14.5.4.2.4.1. Rheumatoid Factor Test
14.5.4.2.4.2. Anti CCP Test
14.5.4.2.4.3. Antistreptolysin O Test
14.5.4.2.5.
Gastric
Function Test
14.5.4.2.5.1. Pepsinogen IÂ
Test
14.5.4.2.5.2. Pepsinogen II (PGII) Test
14.5.4.2.6.
Liver
Test
14.5.4.2.6.1. Prealbumin Blood Test
14.5.4.2.6.2. Transferrin Blood Test
14.5.4.2.6.3. Complement 4 Blood Test
14.5.4.2.6.4. Others
14.5.4.2.7.
Hormone
Test
14.5.4.2.7.1. Thyroid Stimulating Hormone protein test
14.5.4.2.7.2. Total Thyroxine Test
14.5.4.2.7.3. Human Chorionic Gonadotropin Test
14.5.4.2.7.4. Others
14.5.4.2.8.
Autoimmunity
Test
14.5.4.2.8.1. Immune Globulin A Test
14.5.4.2.8.2. Immune Globulin M Test
14.5.4.2.8.3. Immune Globulin E Test
14.5.4.2.8.4. Others
14.5.4.2.9.
Others
14.5.4.3.
Kuwait Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.4.3.1.
Hospitals
and clinics
14.5.4.3.2.
Research
centers and Laboratories
14.5.4.3.3.
Others
14.5.5. South Africa
14.5.5.1.
South
Africa Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
14.5.5.1.1.
In vivo
diagnostic
14.5.5.1.2.
In vitro
diagnostic
14.5.5.1.2.1. Clinical Biochemical
14.5.5.1.2.2. Immunodiagnostic reagents
14.5.5.1.2.3. Molecular Diagnostic
14.5.5.2.
South
Africa Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
14.5.5.2.1.
Cardiovascular
Test
14.5.5.2.1.1. Human Fatty Acid Binding Protein Test
14.5.5.2.1.2. Cardiac Troponin Test
14.5.5.2.1.3. Homocysteine Test
14.5.5.2.1.4. Others
14.5.5.2.2.
Infection
TestÂ
14.5.5.2.3.
Renal
Function Test
14.5.5.2.3.1. Hemoglobin A1c Test
14.5.5.2.3.2. Microalbumin Test
14.5.5.2.3.3. Cystine Test
14.5.5.2.3.4. Retinol Binding Protein Test
14.5.5.2.3.5. Others
14.5.5.2.4.
Rheumatism
Test
14.5.5.2.4.1. Rheumatoid Factor Test
14.5.5.2.4.2. Anti CCP Test
14.5.5.2.4.3. Antistreptolysin O Test
14.5.5.2.5.
Gastric
Function Test
14.5.5.2.5.1. Pepsinogen IÂ
Test
14.5.5.2.5.2. Pepsinogen II (PGII) Test
14.5.5.2.6.
Liver
Test
14.5.5.2.6.1. Prealbumin Blood Test
14.5.5.2.6.2. Transferrin Blood Test
14.5.5.2.6.3. Complement 4 Blood Test
14.5.5.2.6.4. Others
14.5.5.2.7.
Hormone
Test
14.5.5.2.7.1. Thyroid Stimulating Hormone protein test
14.5.5.2.7.2. Total Thyroxine Test
14.5.5.2.7.3. Human Chorionic Gonadotropin Test
14.5.5.2.7.4. Others
14.5.5.2.8.
Autoimmunity
Test
14.5.5.2.8.1. Immune Globulin A Test
14.5.5.2.8.2. Immune Globulin M Test
14.5.5.2.8.3. Immune Globulin E Test
14.5.5.2.8.4. Others
14.5.5.2.9.
Others
14.5.5.3.
South
Africa Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.5.3.1.
Hospitals
and clinics
14.5.5.3.2.
Research
centers and Laboratories
14.5.5.3.3.
Others
14.5.6. Rest of Middle East & Africa
14.5.6.1.
Rest of
Middle East & Africa Diagnostic Reagents Market Revenue (US$ Mn) and
Forecasts, By Type
14.5.6.1.1.
In vivo
diagnostic
14.5.6.1.2.
In vitro
diagnostic
14.5.6.1.2.1. Clinical Biochemical
14.5.6.1.2.2. Immunodiagnostic reagents
14.5.6.1.2.3. Molecular Diagnostic
14.5.6.2.
Rest of
Middle East & Africa Diagnostic Reagents Market Revenue (US$ Mn) and
Forecasts, By Test Type
14.5.6.2.1.
Cardiovascular
Test
14.5.6.2.1.1. Human Fatty Acid Binding Protein Test
14.5.6.2.1.2. Cardiac Troponin Test
14.5.6.2.1.3. Homocysteine Test
14.5.6.2.1.4. Others
14.5.6.2.2.
Infection
TestÂ
14.5.6.2.3.
Renal
Function Test
14.5.6.2.3.1. Hemoglobin A1c Test
14.5.6.2.3.2. Microalbumin Test
14.5.6.2.3.3. Cystine Test
14.5.6.2.3.4. Retinol Binding Protein Test
14.5.6.2.3.5. Others
14.5.6.2.4.
Rheumatism
Test
14.5.6.2.4.1. Rheumatoid Factor Test
14.5.6.2.4.2. Anti CCP Test
14.5.6.2.4.3. Antistreptolysin O Test
14.5.6.2.5.
Gastric
Function Test
14.5.6.2.5.1. Pepsinogen IÂ
Test
14.5.6.2.5.2. Pepsinogen II (PGII) Test
14.5.6.2.6.
Liver
Test
14.5.6.2.6.1. Prealbumin Blood Test
14.5.6.2.6.2. Transferrin Blood Test
14.5.6.2.6.3. Complement 4 Blood Test
14.5.6.2.6.4. Others
14.5.6.2.7.
Hormone
Test
14.5.6.2.7.1. Thyroid Stimulating Hormone protein test
14.5.6.2.7.2. Total Thyroxine Test
14.5.6.2.7.3. Human Chorionic Gonadotropin Test
14.5.6.2.7.4. Others
14.5.6.2.8.
Autoimmunity
Test
14.5.6.2.8.1. Immune Globulin A Test
14.5.6.2.8.2. Immune Globulin M Test
14.5.6.2.8.3. Immune Globulin E Test
14.5.6.2.8.4. Others
14.5.6.2.9.
Others
14.5.6.3.
Rest of
Middle East & Africa Diagnostic Reagents Market Revenue (US$ Mn) and
Forecasts, By End Users
14.5.6.3.1.
Hospitals
and clinics
14.5.6.3.2.
Research
centers and Laboratories
14.5.6.3.3.
Others
14.6. Key Segment for Channeling Investments
14.6.1. By Country
14.6.2. By Type
14.6.3. By Test Type
14.6.4. By End Users
15. Latin America Diagnostic Reagents Market
Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Latin America Diagnostic Reagents Market
Revenue (US$ Mn)
15.2. Latin America Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By Type
15.2.1. In vivo diagnostic
15.2.2. In vitro diagnostic
15.2.2.1.
Clinical
Biochemical
15.2.2.2.
Immunodiagnostic
reagents
15.2.2.3.
Molecular
Diagnostic
15.3. Latin America Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By Test Type
15.3.1. Cardiovascular Test
15.3.1.1.
Human
Fatty Acid Binding Protein Test
15.3.1.2.
Cardiac Troponin
Test
15.3.1.3.
Homocysteine
Test
15.3.1.4.
Others
15.3.2. Infection TestÂ
15.3.3. Renal Function Test
15.3.3.1.
Hemoglobin
A1c Test
15.3.3.2.
Microalbumin
Test
15.3.3.3.
Cystine
Test
15.3.3.4.
Retinol
Binding Protein Test
15.3.3.5.
Others
15.3.4. Rheumatism Test
15.3.4.1.
Rheumatoid
Factor Test
15.3.4.2.
Anti CCP
Test
15.3.4.3.
Antistreptolysin
O Test
15.3.5. Gastric Function Test
15.3.5.1.
Pepsinogen
IÂ Test
15.3.5.2.
Pepsinogen
II (PGII) Test
15.3.6. Liver Test
15.3.6.1.
Prealbumin
Blood Test
15.3.6.2.
Transferrin
Blood Test
15.3.6.3.
Complement
4 Blood Test
15.3.6.4.
Others
15.3.7. Hormone Test
15.3.7.1.
Thyroid
Stimulating Hormone protein test
15.3.7.2.
Total Thyroxine
Test
15.3.7.3.
Human
Chorionic Gonadotropin Test
15.3.7.4.
Others
15.3.8. Autoimmunity Test
15.3.8.1.
Immune
Globulin A Test
15.3.8.2.
Immune
Globulin M Test
15.3.8.3.
Immune
Globulin E Test
15.3.8.4.
Others
15.3.9. Others
15.4. Latin America Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By End Users
15.4.1. Hospitals and clinics
15.4.2. Research centers and Laboratories
15.4.3. Others
15.5. Latin America Diagnostic Reagents Market
Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1.
Brazil Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Type
15.5.1.1.1.
In vivo
diagnostic
15.5.1.1.2.
In vitro
diagnostic
15.5.1.1.2.1. Clinical Biochemical
15.5.1.1.2.2. Immunodiagnostic reagents
15.5.1.1.2.3. Molecular Diagnostic
15.5.1.2.
Brazil Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
15.5.1.2.1.
Cardiovascular
Test
15.5.1.2.1.1. Human Fatty Acid Binding Protein Test
15.5.1.2.1.2. Cardiac Troponin Test
15.5.1.2.1.3. Homocysteine Test
15.5.1.2.1.4. Others
15.5.1.2.2.
Infection
TestÂ
15.5.1.2.3.
Renal
Function Test
15.5.1.2.3.1. Hemoglobin A1c Test
15.5.1.2.3.2. Microalbumin Test
15.5.1.2.3.3. Cystine Test
15.5.1.2.3.4. Retinol Binding Protein Test
15.5.1.2.3.5. Others
15.5.1.2.4.
Rheumatism
Test
15.5.1.2.4.1. Rheumatoid Factor Test
15.5.1.2.4.2. Anti CCP Test
15.5.1.2.4.3. Antistreptolysin O Test
15.5.1.2.5.
Gastric
Function Test
15.5.1.2.5.1. Pepsinogen IÂ
Test
15.5.1.2.5.2. Pepsinogen II (PGII) Test
15.5.1.2.6.
Liver
Test
15.5.1.2.6.1. Prealbumin Blood Test
15.5.1.2.6.2. Transferrin Blood Test
15.5.1.2.6.3. Complement 4 Blood Test
15.5.1.2.6.4. Others
15.5.1.2.7.
Hormone
Test
15.5.1.2.7.1. Thyroid Stimulating Hormone protein test
15.5.1.2.7.2. Total Thyroxine Test
15.5.1.2.7.3. Human Chorionic Gonadotropin Test
15.5.1.2.7.4. Others
15.5.1.2.8.
Autoimmunity
Test
15.5.1.2.8.1. Immune Globulin A Test
15.5.1.2.8.2. Immune Globulin M Test
15.5.1.2.8.3. Immune Globulin E Test
15.5.1.2.8.4. Others
15.5.1.2.9.
Others
15.5.1.3.
Brazil Diagnostic
Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1.3.1.
Hospitals
and clinics
15.5.1.3.2.
Research
centers and Laboratories
15.5.1.3.3.
Others
15.5.2. Argentina
15.5.2.1.
Argentina
Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Type
15.5.2.1.1.
In vivo
diagnostic
15.5.2.1.2.
In vitro
diagnostic
15.5.2.1.2.1. Clinical Biochemical
15.5.2.1.2.2. Immunodiagnostic reagents
15.5.2.1.2.3. Molecular Diagnostic
15.5.2.2.
Argentina
Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By Test Type
15.5.2.2.1.
Cardiovascular
Test
15.5.2.2.1.1. Human Fatty Acid Binding Protein Test
15.5.2.2.1.2. Cardiac Troponin Test
15.5.2.2.1.3. Homocysteine Test
15.5.2.2.1.4. Others
15.5.2.2.2.
Infection
TestÂ
15.5.2.2.3.
Renal
Function Test
15.5.2.2.3.1. Hemoglobin A1c Test
15.5.2.2.3.2. Microalbumin Test
15.5.2.2.3.3. Cystine Test
15.5.2.2.3.4. Retinol Binding Protein Test
15.5.2.2.3.5. Others
15.5.2.2.4.
Rheumatism
Test
15.5.2.2.4.1. Rheumatoid Factor Test
15.5.2.2.4.2. Anti CCP Test
15.5.2.2.4.3. Antistreptolysin O Test
15.5.2.2.5.
Gastric
Function Test
15.5.2.2.5.1. Pepsinogen IÂ
Test
15.5.2.2.5.2. Pepsinogen II (PGII) Test
15.5.2.2.6.
Liver
Test
15.5.2.2.6.1. Prealbumin Blood Test
15.5.2.2.6.2. Transferrin Blood Test
15.5.2.2.6.3. Complement 4 Blood Test
15.5.2.2.6.4. Others
15.5.2.2.7.
Hormone
Test
15.5.2.2.7.1. Thyroid Stimulating Hormone protein test
15.5.2.2.7.2. Total Thyroxine Test
15.5.2.2.7.3. Human Chorionic Gonadotropin Test
15.5.2.2.7.4. Others
15.5.2.2.8.
Autoimmunity
Test
15.5.2.2.8.1. Immune Globulin A Test
15.5.2.2.8.2. Immune Globulin M Test
15.5.2.2.8.3. Immune Globulin E Test
15.5.2.2.8.4. Others
15.5.2.2.9.
Others
15.5.2.3.
Argentina
Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.2.3.1.
Hospitals
and clinics
15.5.2.3.2.
Research
centers and Laboratories
15.5.2.3.3.
Others
15.5.3. Rest of Latin America
15.5.3.1.
Rest of
Latin America Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By
Type
15.5.3.1.1.
In vivo
diagnostic
15.5.3.1.2.
In vitro
diagnostic
15.5.3.1.2.1. Clinical Biochemical
15.5.3.1.2.2. Immunodiagnostic reagents
15.5.3.1.2.3. Molecular Diagnostic
15.5.3.2.
Rest of
Latin America Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By
Test Type
15.5.3.2.1.
Cardiovascular
Test
15.5.3.2.1.1. Human Fatty Acid Binding Protein Test
15.5.3.2.1.2. Cardiac Troponin Test
15.5.3.2.1.3. Homocysteine Test
15.5.3.2.1.4. Others
15.5.3.2.2.
Infection
TestÂ
15.5.3.2.3.
Renal
Function Test
15.5.3.2.3.1. Hemoglobin A1c Test
15.5.3.2.3.2. Microalbumin Test
15.5.3.2.3.3. Cystine Test
15.5.3.2.3.4. Retinol Binding Protein Test
15.5.3.2.3.5. Others
15.5.3.2.4.
Rheumatism
Test
15.5.3.2.4.1. Rheumatoid Factor Test
15.5.3.2.4.2. Anti CCP Test
15.5.3.2.4.3. Antistreptolysin O Test
15.5.3.2.5.
Gastric
Function Test
15.5.3.2.5.1. Pepsinogen IÂ
Test
15.5.3.2.5.2. Pepsinogen II (PGII) Test
15.5.3.2.6.
Liver
Test
15.5.3.2.6.1. Prealbumin Blood Test
15.5.3.2.6.2. Transferrin Blood Test
15.5.3.2.6.3. Complement 4 Blood Test
15.5.3.2.6.4. Others
15.5.3.2.7.
Hormone
Test
15.5.3.2.7.1. Thyroid Stimulating Hormone protein test
15.5.3.2.7.2. Total Thyroxine Test
15.5.3.2.7.3. Human Chorionic Gonadotropin Test
15.5.3.2.7.4. Others
15.5.3.2.8.
Autoimmunity
Test
15.5.3.2.8.1. Immune Globulin A Test
15.5.3.2.8.2. Immune Globulin M Test
15.5.3.2.8.3. Immune Globulin E Test
15.5.3.2.8.4. Others
15.5.3.2.9.
Others
15.5.3.3.
Rest of
Latin America Diagnostic Reagents Market Revenue (US$ Mn) and Forecasts, By End
Users
15.5.3.3.1.
Hospitals
and clinics
15.5.3.3.2.
Research
centers and Laboratories
15.5.3.3.3.
Others
15.6. Key Segment for Channeling Investments
15.6.1. By Country
15.6.2. By Type
15.6.3. By Test Type
15.6.4. By End Users
16. Competitive Benchmarking
16.1. Brand Benchmarking
16.2. Market Share Analysis, 2021
16.3. Global Presence and Growth Strategies
16.3.1. Mergers and Acquisitions
16.3.2. Product Launches
16.3.3. Investments Trends
16.3.4. R&D Initiatives
17. Player Profiles
17.1. Agappe Diagnostics Ltd
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. Agilent Technologies, Inc.
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business Strategies
17.3. BD
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business Strategies
17.4. bioMérieux SA
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business Strategies
17.5. Calbiotech
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business Strategies
17.6. DiaSorin S.p.A
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business Strategies
17.7. F. Hoffmann-La Roche Ltd
17.7.1. Company Details
17.7.2. Company Overview
17.7.3. Product Offerings
17.7.4. Key Developments
17.7.5. Financial Analysis
17.7.6. SWOT Analysis
17.7.7. Business Strategies
17.8. Hipro Biotechnology Co.,Ltd.
17.8.1. Company Details
17.8.2. Company Overview
17.8.3. Product Offerings
17.8.4. Key Developments
17.8.5. Financial Analysis
17.8.6. SWOT Analysis
17.8.7. Business Strategies
17.9. Lanyi Technology Group
17.9.1. Company Details
17.9.2. Company Overview
17.9.3. Product Offerings
17.9.4. Key Developments
17.9.5. Financial Analysis
17.9.6. SWOT Analysis
17.9.7. Business Strategies
17.10. Lifecycle Biotechnologies
17.10.1. Company Details
17.10.2. Company Overview
17.10.3. Product Offerings
17.10.4. Key Developments
17.10.5. Financial Analysis
17.10.6. SWOT Analysis
17.10.7. Business Strategies
17.11. Meridian Bioscience, Inc.
17.11.1. Company Details
17.11.2. Company Overview
17.11.3. Product Offerings
17.11.4. Key Developments
17.11.5. Financial Analysis
17.11.6. SWOT Analysis
17.11.7. Business Strategies
17.12. Randox Laboratories Ltd
17.12.1. Company Details
17.12.2. Company Overview
17.12.3. Product Offerings
17.12.4. Key Developments
17.12.5. Financial Analysis
17.12.6. SWOT Analysis
17.12.7. Business Strategies
17.13. Shenzhen Mindray Bio-Medical Electronics Co.,
Ltd.
17.13.1. Company Details
17.13.2. Company Overview
17.13.3. Product Offerings
17.13.4. Key Developments
17.13.5. Financial Analysis
17.13.6. SWOT Analysis
17.13.7. Business Strategies
17.14. Siemens Healthcare Private Limited
17.14.1. Company Details
17.14.2. Company Overview
17.14.3. Product Offerings
17.14.4. Key Developments
17.14.5. Financial Analysis
17.14.6. SWOT Analysis
17.14.7. Business Strategies
17.15. Thermo Fisher Scientific, Inc.
17.15.1. Company Details
17.15.2. Company Overview
17.15.3. Product Offerings
17.15.4. Key Developments
17.15.5. Financial Analysis
17.15.6. SWOT Analysis
17.15.7. Business Strategies
17.16. Other Market Participants
18. Key Findings
Note: This ToC is tentative and
can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.